(Press-News.org) ANN ARBOR—Zebrafish with very weak muscles helped scientists decode the elusive genetic mutation responsible for Native American myopathy, a rare, hereditary muscle disease that afflicts Native Americans in North Carolina.
Scientists led by John Kuwada, professor of molecular, cellular and developmental biology at the University of Michigan, and Hiromi Hirata of the National Institute of Genetics in Japan originally identified the gene in mutant zebrafish that exhibited severe muscle weakness. Native American myopathy causes muscle weakness from birth and other severe problems that can lead to death before adulthood.
The findings appear in the journal Nature Communications.
The responsible gene encodes for a muscle protein called Stac3, which in turn regulates a physiological process required for muscle contraction. The muscles of zebrafish and people with the genetic mutation don't make normal Stac3 protein and the muscles don't contract effectively.
Scientists established the importance of Stac3 for muscle function in zebrafish by studying the small fish physiologically and genetically. Scientists then looked at the human version of the gene, and found that the gene was mutated in people suffering from Native American myopathy.
For many degenerative muscle diseases few drugs help, largely because scientists don't know the genes responsible for many of these muscle diseases, making it difficult to develop drugs and other therapies that target the condition. The discovery of the gene for Native American myopathy, however, may help develop drugs to treat the myopathy, as well as other related muscle diseases.
###
Study: http://dx.doi.org/10.1038/ncomms2952
John Kuwada: http://labs.mcdb.lsa.umich.edu/labs/kuwada
Department of Molecular, Cellular and Developmental Biology: http://www.lsa.umich.edu/mcdb
Zebrafish help identify mutant gene in rare muscle disease
2013-06-04
ELSE PRESS RELEASES FROM THIS DATE:
Stories help patients make health decisions, MU researcher says
2013-06-04
COLUMBIA, Mo. –Stories often appear in health communication in order to encourage individuals to change behaviors, such as smoking or not wearing sunscreen. A University of Missouri researcher studied how stories influence patients' decision-making when behavior change is not the desired outcome of the health communication.
"Patient stories can be very persuasive, and people tend to seek stories from others when they make health decisions," said Victoria Shaffer, an assistant professor of health sciences and psychological sciences at MU. "We were concerned about whether ...
Meeting online leads to happier, more enduring marriages
2013-06-04
More than a third of marriages between 2005 and 2012 began online, according to new research at the University of Chicago, which also found that online couples have happier, longer marriages.
Although the study did not determine why relationships that started online were more successful, the reasons may include the strong motivations of online daters, the availability of advance screening, and the sheer volume of opportunities online.
"These data suggest that the Internet may be altering the dynamics and outcomes of marriage itself," said the study's lead author, ...
Potential new way to suppress tumor growth discovered
2013-06-04
Researchers at the University of California, San Diego School of Medicine, with colleagues at the University of Rochester Medical Center, have identified a new mechanism that appears to suppress tumor growth, opening the possibility of developing a new class of anti-cancer drugs.
Writing in this week's online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), Willis X. Li, PhD, a professor in the Department of Medicine at UC San Diego, reports that a particular form of a signaling protein called STAT5A stabilizes the formation of heterochromatin ...
New strategy for defeating neuroblastoma
2013-06-04
Researchers at Karolinska Institutet in Sweden have found a promising strategy for defeating neuroblastoma – a malignant form of cancer in children – that focuses on the so-called MYCN protein. A specific chemical molecule helps to break down MYCN, which either kills the cancer cell or makes it mature into a harmless neuron. The discovery, which is published in the scientific journal PNAS, raises hopes for new and more effective treatments in the future.
Neuroblastoma is the third most common form of cancer in children. It usually develops before the age of two and affects ...
Expanding Medicaid is best financial option for states, study finds
2013-06-04
States that choose not to expand Medicaid under federal health care reform will leave millions of their residents without health insurance and increase spending, at least in the short term, on the cost of treating uninsured residents, according to a new RAND Corporation study.
If 14 states decide not to expand Medicaid under the Affordable Care Act as intended by their governors, those state governments collectively will spend $1 billion more on uncompensated care in 2016 than they would if Medicaid is expanded.
In addition, those 14 state governments would forego ...
Early-life risk factors account for racial and ethnic disparities in childhood obesity
2013-06-04
Early-life risk factors -- most of which could be changed -- appear to explain the recognized racial and ethnic disparities in the incidence of childhood overweight and obesity. In a report being published online in JAMA Pediatrics, a team of researchers report a prospective study finding that increased prevalence of obesity and overweight among black and Hispanic 7-year-olds could largely be explained by risk factors such as rapid infant weight gain, early introduction of solid foods and a lack of exclusive breast feeding.
"We know that, already by the age of 2, black ...
New biomolecular archaeological evidence points to the beginnings of viniculture in France
2013-06-04
PHILADELPHIA, PA June 2013—France is renowned the world over as a leader in the crafts of viticulture and winemaking—but the beginnings of French viniculture have been largely unknown, until now.
Imported ancient Etruscan amphoras and a limestone press platform, discovered at the ancient port site of Lattara in southern France, have provided the earliest known biomolecular archaeological evidence of grape wine and winemaking—and point to the beginnings of a Celtic or Gallic vinicultural industry in France circa 500-400 BCE. Details of the discovery are published as "The ...
USC report: Law dramatically reduced hospital prices for the uninsured
2013-06-04
To comply with a statewide "fair pricing" law, hospitals throughout California have significantly lowered prices to uninsured patients, with nearly all even going beyond the state mandate and offering free care to those below the poverty line.
The surprising success of the legislation represents the beginnings of a safety net not in place for other states.
Some 6.8 million people in California lack health insurance, often relying on hospital emergency departments for healthcare. Based on hospital billing plans, those visits can rack up huge bills that the uninsured ...
Turning point for early human diets occurred 3.5 million years ago
2013-06-04
SAN FRANCISCO (June 3, 2013) — The old saying "You are what you eat" takes on new significance in the most comprehensive analysis to date of early human teeth from Africa. Prior to about 3.5 million years ago, early humans dined almost exclusively on leaves and fruits from trees, shrubs, and herbs—similar to modern-day gorillas and chimpanzees. However, about 3.5 million years ago, early human species like Australopithecus afarensis and Kenyanthropus platyops began to also nosh on grasses, sedges, and succulents—or on animals that ate those plants. Evidence of this ...
New kind of antibiotic may be more effective at fighting tuberculosis, anthrax, and other diseases
2013-06-04
Diseases such as tuberculosis, anthrax, and shigellosis -- a severe food-borne illness -- eventually could be treated with an entirely new and more-effective kind of antibiotic, thanks to a team of scientists led by Kenneth Keiler, an associate professor of biochemistry and molecular biology at Penn State University. In a research paper that will be published in the journal Proceedings of the National Academy of Sciences during the week beginning 3 June 2013, the team describes 46 previously untested molecules that target and disrupt an important step in the process of ...